Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.
Daniel Bateman on Reminiscence Therapy

“It really focuses on maintaining the dignity of people with dementia,” Dr. Bateman tells U.S. News and World Report

Regenstrief researcher Daniel Bateman, M.D., is intrigued by reminiscence therapy and its possibilities.

Dr. Bateman spoke to U.S. News and World Report about reminiscence therapy programs like the one at Glenner Town Square in California. Reminiscence therapy is the use of sights, smells, and other sensory stimuli to evoke memories from a person’s past. The senior day care center provides the therapy through immersive environments from the 1950s, such as a department store and a barber, scenes that would be familiar to the people served by the facility.

There is currently no medicine that reverses Alzheimer’s disease and related dementias or significantly eases symptoms, so quality-of-life initiatives have become more important.

“It’s cutting edge and it’s exciting work,” Dr. Bateman said of reminiscence therapy. “One of the great pieces about the concept is that it really focuses on maintaining the dignity and the humanity of people with dementia, which can often be lost.”

Dr. Bateman’s primary research interest is studying and implementing innovative approaches to measure and treat behavioral and psychological symptoms of dementia. He focuses on the use of technology interventions to improve the health of people with dementia and their caregivers.

You can read Dr. Bateman’s interview here.

In addition to his position at Regenstrief, Dr. Batmen is an assistant professor at the Indiana University School of Medicine, an implementation scientist with the Center for Health Innovation and Implementation Science, and a co-investigator at the Indiana Alzheimer Disease Center.

MEDIA CONTACTS:
John Erickson
Regenstrief Institute
prteam@regenstrief.org

Related News

Jul 28, 2021 • News
Foundation of trust needed to have successful shared decision-making on pain treatment 
Editorial examines complexities of relationships and communication   A foundation of trust is crucial to help patients with chronic pain have productive conversations about pain management with their clinicians as well as better overall health outcomes, especially when it comes to opioids, according to a viewpoint article in the Journal of General Internal Medicine written by authors from Regenstrief Institute, the U.S. Department of Veterans Affairs and…
Continue Reading >
Jul 26, 2021 • News
Media coverage of health, especially disease screening, is often not sufficiently nuanced
The media covers health extensively, at no time more than during the pandemic. But that coverage often is not sufficiently nuanced. In a JAMA Internal Medicine commentary focusing on media coverage of disease screening, Regenstrief Institute Vice President and Indiana University School of Medicine Associate Dean Aaron E. Carroll, M.D., and IU School of Medicine…
Continue Reading >